Mabion, a biotech-focused CDMO offering end-to-end services, has launched a €500,000 oncology services contest at BIO International Convention 2025. This initiative hopes to accelerate the development of recombinant protein-based cancer therapies. 

The contest will culminate at CPHI Worldwide in Frankfurt this October, spotlighting promising biotech’s ready to scale their innovation.

The initiative provides a simplified entry process via QR code at Mabion’s booth and a dedicated landing page. Selected entrants will be guided through pre-qualification, NDAs, and proposal shaping with Mabion’s business development team.

The winner will receive a €500,000 credit toward Mabion’s integrated CDMO capabilities, including process and analytical development, upstream/downstream processing, and clinical supply manufacturing.

Runner-up entries may also be invited into partnership discussions.

An independent jury of experts will evaluate entries based on scientific merit, feasibility, and potential patient impact. 

The jury includes:

• Prof. Tadeusz Pietrucha: Medical Biotechnology Department at Medical University of Łódź – Translational Oncology Expert
• Prof. Przemysław Juszczyński: Department of Experimental Hematology and Transfusionology at Lazarski University – Scientific Innovation Specialist
• Prof. Gestur Vidarsson: PI and head of Immunoglobulin Research at Sanquin Research at the Utrecht University and Chair of the Immunoglobulin Biotherapeutics group – Leading Expert in Immunoglobulin-based Biotherapeutics
• Alicja Santos: Ph.D. and CEO of Polonium Foundation – Biotech Talent Advocate
• Julita Balcerek: Ph.D. and COO of Mabion – CDMO Strategy Leader

“Despite unprecedented scientific advances, many oncology treatments still face hurdles at the funding stage,” said Julita Balcerek, Ph.D., COO at Mabion. “This contest is our invitation to innovators who just need the right partner. We’re offering more than a prize; we’re offering a path to impact.”

The launch is supported by a multi-channel campaign featuring LinkedIn promotions, media outreach, email engagement, and in-booth activations at BIO and CPHI.